Biography
Main responsibilities
Nathan works with fund managers and analysts in assessing Company corporate governance and remuneration arrangements, and engages with companies on material governance issues as part of Aviva Investors' investment considerations.
He has a key role in reviewing, updating and implementing the firm's voting policies. Nathan is also responsible for evidencing Aviva Investors' public voting-related disclosures and in reviewing the effectiveness of Aviva Investors' voting and engagement.
Nathan represents Aviva Investors on the Investment Association's Remuneration and Share Schemes Committee, Global Institutional Governance Network (GIGN) and the Asian Corporate Governance Association (ACGA).
Experience and qualifications
He joined Aviva Investors in 2002 after a year at Northern Trust custodian bank where he supervised the outsourcing of proxy voting to ISS.
Prior to this, Nathan was with The Manifest Voting Agency where he gained his corporate governance experience as a research analyst and later moved on to the Voting Operations Department where he was responsible for the effective delivery of proxy vote instructions and client reporting on behalf of institutional shareholder clients, pension funds and local authorities.
Related profiles
Agneta Bamania
Sustainable Investments Director
Greta Talbot-Jones
Director, Natural Capital / Portfolio Manager, Carbon Removal Fund
Steve Waygood
Chief Responsible Investment Officer
Richard Butters
Head of Stewardship
Eugenie Mathieu
Nature Stewardship Lead
Thomas Dillon
Head of Sovereign ESG
We know what it takes to make a difference
It takes working together to drive sustainable transition across People, Climate, and Earth. It takes Aviva Investors.
You might also be interested in
-
Confronting a permacrisis? The intersection between antimicrobial resistance, climate change and biodiversity loss
23 Nov. 2022
Will a warmer and less biodiverse world give pathogens new opportunities, and do we have the tools to confront disease? This report discusses the complex intersection of three planetary crises and calls for urgent action to slow resistance to antimicrobial drugs – an obvious public health emergency.